Rachel Frank
Head of Investor Relations
Replay available
Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2023 Earnings Call
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) Q4 2023 earnings conference call, held 2024-02-28. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sanj K. Patel
Chief Executive Officer
Ross Moat
Chief Commercial Officer
John Paolini
Chief Medical Officer
Mark Ragosa
Chief Financial Officer
Unipam Rama
Analyst, JPMorgan
Paul Troy
Analyst, Goldman Sachs
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Kiniksa Pharmaceuticals International, Plc.
Replay transcript excerpt
WEBVTT 00:00:00.089 -- 00:00:04.252 Good day and thank you for standing by. Welcome to the Connexus Pharmaceuticals' fourth 00:00:04.252 -- 00:00:08.095 quarter and full year 2023 earnings conference call. 00:00:08.095 -- 00:00:11.297 At this time, all participants are in a lesson-only mode. 00:00:11.297 -- 00:00:14.820 After the speaker's presentation, there will be a question and answer session. 00:00:14.820 -- 00:00:19.884 To ask a question during this session, you will need to press star 1-1 on your telephone. 00:00:19.884 -- 00:00:23.467 You will then hear an automated message advising you your hand is raised. 00:00:23.467 -- 00:00:26.549 To withdraw your question, please press star 1-1 again. 00:00:26.549 -- 00:00:29.730 Please be advised that today's conference is being recorded. 00:00:29.730 -- 00:00:33.311 I would now like to hand the conference over to your speaker today, Rachel Frank, Head 00:00:33.311 -- 00:00:36.913 of Investor Relations. Please go ahead. 00:00:36.913 -- 00:00:40.434 Thank you, Operator. Good morning, everyone, and thank you for joining Connexus Call 00:00:40.434 -- 00:00:45.816 to discuss our fourth quarter and full year 2023 financial results and recent portfolio 00:00:45.816 -- 00:00:50.558 execution. A press release highlighting these results can be found on our website under 00:00:50.558 -- 00:00:52.838 the Investor section. 00:00:52.838 -- 00:00:55.519 As for the agenda, our Chief Executive Officer, Sanj K. 00:00:55.519 -- 00:00:59.980 Patel, will start with an introduction. Ross Moat, our Chief Commercial Officer, will 00:00:59.980 -- 00:01:03.402 provide an update on our ARCLPS commercial execution. 00:01:03.402 -- 00:01:07.525 John Paolini, our Chief Medical Officer, will review the Abby's ProveArt program and 00:01:07.525 -- 00...